Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Enfrentando juntos: Intervenções baseadas em casais para o câncer (CCST2)

13 de novembro de 2026 atualizado por: Duke University

Treinamento de habilidades de comunicação de casal para câncer avançado

The objective of the proposed study is to evaluate the Couple Communication Skills Training (CCST) intervention in 250 patients with advanced cancer and their spouses/intimate partners. Couples will be randomized 1:1 to receive either the CCST or to an attention control condition (Healthy Living Information; HLI). We will evaluate CCST effects on a range of patient and partner relationship and psychological outcomes.

Visão geral do estudo

Status

Concluído

Condições

Intervenção / Tratamento

Descrição detalhada

For patients and their intimate partners, advanced cancer poses significant challenges that can negatively impact both individuals and the couple's collective well-being. Couples' ability to communicate openly and effectively with each other about cancer-related concerns can improve their psychological adjustment and quality of their relationship. Open and effective communication may also lead to better symptom management and goal-concordant care. However, many couples report difficulties communicating about cancer, even in the context of overall satisfying relationships. This can have a number of deleterious consequences, including deficits in emotional support, decreases in intimacy and relationship quality, and increased psychological distress. Thus, interventions designed to facilitate effective communication between cancer patients and their partners are likely to have beneficial effects on both individual and relationship functioning.

Prior research, including studies conducted by our team, has found that couple-based interventions that target communication lead to positive outcomes for cancer patients and their partners. However, most prior studies have been limited by reliance on an in-person treatment delivery format which keeps many couples from participating. In addition, prior studies have not targeted interventions to couples who are most likely to benefit. There is increasing evidence that psychosocial interventions for cancer, including couple-based interventions, should be targeted to those at risk of poor outcomes. Our prior research indicates that couples who report communication difficulties (e.g., high levels of holding back from discussing cancer-related concerns) have increased psychological distress and poorer relationship functioning and are most likely to benefit from a couple communication intervention specifically designed to addressed their communication problems.

The specific aims of this study are (1)To determine whether CCST significantly improves patients' and partners' individual psychological adjustment (i.e., psychological distress, life completion) and patient health and health care outcomes (physical well-being, symptom distress, advance care planning discussions and completion of advance directives, hospitalizations, and emergency department visits) compared to an education condition. (2) To determine whether, for couples receiving the CCST intervention, improvements in psychological adjustment, relationship functioning, and patient health are mediated by improvements in their communication, including objective measures of communication quality and communal coping (e.g., "we-talk") derived from couple conversations and self-reported protective buffering. (3) To examine differences in response to the CCST intervention for patients versus partners, for male versus female participants, and for patients with different cancer diagnoses (breast, lung, GI, GU). (4) To conduct an implementation-related process evaluation of the intervention.

Tipo de estudo

Intervencional

Inscrição (Real)

440

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • North Carolina
      • Durham, North Carolina, Estados Unidos, 27705
        • Duke University Medical Center

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  1. Married or in a committed intimate relationship
  2. Diagnosis of one the following advanced cancers: Stage IIIB or IV non-small cell lung cancer or extensive stage small cell lung cancer, Stage III pancreatic cancer or Stage IV GI cancer, Stage IV GU cancer, Stage IV breast cancer and GYN cancer Stage III-IV ovarian, IV uterine, IV cervical.
  3. Both members of the couple must speak and read English.
  4. Patient and/or partner scores >=1.0 on the Holding Back screen.

Exclusion Criteria:

  1. Patient lacks capacity for interview (documented diagnosis of active psychosis or dementia) or is unable to provide informed consent as assessed by research staff.
  2. Patient has a life expectancy < 6 months as estimated by his/her treating oncologist.
  3. Patient or partner is physically impaired in such a way that precludes the use of a computer or videoconferencing.
  4. Patient or partner is too sick to participate, as judged by the oncologist or research staff.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Outro: Couple Communication and Support

CCST includes components to assist couples in communicating effectively, decreasing avoidance of important cancer-related issues, and providing each other with support. It includes training in skills for sharing one's thoughts and feelings and listening to one's partner and responding in a supportive manner, and joint problem solving. Participants will be asked to participate inactivities at home between sessions to strengthen skills acquisition.

Participants attend six 60-minute sessions consisting of education and skills training to enhance cancer-related communication.

Outros nomes:
  • CCST
Outro: Healthy Lifestyle Informaion

Healthy Lifestyle Information provides couples with health information relevant to cancer in a supportive environment. Sessions focus on the following topics: fatigue, sleep disturbance, nutrition, physical activity, survivorship care plans, and palliative care. Patients and partners are invited to discuss their experiences around the session topics with the therapist and ask questions about the information presented.

Participants attend attend six 60-minute sessions consisting of information and support across a range of cancer-related topics.

Outros nomes:
  • HLI

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Changes in patient relationship functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner relationship functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient relationship functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner relationship functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Changes in patient psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient life completion measured by the Life Completion scale of the QUAL-E (higher scores indicate higher completion)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner life completion measured by the Life Completion scale of the QUAL-E Family (higher scores indicate higher completion)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient physical well being as measured by the Physical Well Being subscale of the Functional Assessment of Cancer Therapy scale (higher scores indicate higher physical well being)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient and partner psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in symptom distress as measured by the Condensed Memorial Symptom Assessment Scale (higher scores indicate higher symptom distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient advance care planning discussions (presence or absence, via patient self-report)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient completion of advanced directives (presence or absence, via patient self-report)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient hospitalizations (number of hospitalizations per patient self-report, validated by medical record review)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Prazo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient emergency department visits (number of emergency department visits per patient self-report, validated by medical record review)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Laura Porter, PhD, Duke

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

20 de outubro de 2020

Conclusão Primária (Real)

31 de dezembro de 2025

Conclusão do estudo (Real)

31 de dezembro de 2025

Datas de inscrição no estudo

Enviado pela primeira vez

9 de outubro de 2020

Enviado pela primeira vez que atendeu aos critérios de CQ

15 de outubro de 2020

Primeira postagem (Real)

19 de outubro de 2020

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

13 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • Pro00103232

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .